Eli Lilly and Co
XBER:LLY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eli Lilly and Co
XBER:LLY
|
US |
|
Rainbow Rare Earths Ltd
LSE:RBW
|
GG |
|
Hoteles City Express SAB de CV
BMV:HCITY
|
MX |
|
P
|
Practical Solution PCL
SET:TPS
|
TH |
|
Charles River Laboratories International Inc
NYSE:CRL
|
US |
|
P
|
Petronor E&P ASA
OSE:PNOR
|
NO |
|
J
|
Jay Bharat Maruti Ltd
NSE:JAYBARMARU
|
IN |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SZSE:002365
|
CN |
Relative Value
The Relative Value of one
LLY
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 913.5 EUR,
Eli Lilly and Co
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
LLY Competitors Multiples
Eli Lilly and Co Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Eli Lilly and Co
XBER:LLY
|
860.3B EUR | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.6 | 12.8 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 | |
| FR |
|
Sanofi SA
PAR:SAN
|
92.9B EUR | 2 | 12 | 10.1 | 10.1 |